HealthTrackRx
U.S.-based molecular diagnostic laboratory that provides next-day PCR testing for infectious diseases, multiplex panels, antimicrobial-resistance gene reporting, provider dashboards and clinical resources to support evidence-based treatment decisions for clinicians, employers, payors and patients.
Industries
Nr. of Employees
large (251-1000)
HealthTrackRx
Products
Testing menus
Catalogs of available PCR test panels and specimen collection instructions for different clinical settings.
Respiratory Trends Report
Periodic report and interactive workbook summarizing the top-reported respiratory infections and regional positivity trends.
Chlamydia, Gonorrhea & Trichomonas Panel
Focused molecular test for high-prevalence sexually transmitted infections.
Urinary Tract Infection
Comprehensive molecular PCR panel for identifying bacterial and fungal pathogens associated with urinary tract infections along with antimicrobial resistance markers.
Urinary Tract Infection Syndromic Menu
Targeted multiplex PCR panel for the identification of urinary tract infection pathogens and resistance markers.
HealthTrackRx Employer PCR Testing Solutions
PCR laboratory testing solutions for employer clinics providing fast next-morning test results to mitigate the costs of lost productivity from acute infections.
Testing menus
Catalogs of available PCR test panels and specimen collection instructions for different clinical settings.
Respiratory Trends Report
Periodic report and interactive workbook summarizing the top-reported respiratory infections and regional positivity trends.
Chlamydia, Gonorrhea & Trichomonas Panel
Focused molecular test for high-prevalence sexually transmitted infections.
Urinary Tract Infection
Comprehensive molecular PCR panel for identifying bacterial and fungal pathogens associated with urinary tract infections along with antimicrobial resistance markers.
Urinary Tract Infection Syndromic Menu
Targeted multiplex PCR panel for the identification of urinary tract infection pathogens and resistance markers.
HealthTrackRx Employer PCR Testing Solutions
PCR laboratory testing solutions for employer clinics providing fast next-morning test results to mitigate the costs of lost productivity from acute infections.
Services
Central laboratory service that delivers next-day PCR results across a broad menu of infectious pathogens to support clinical treatment decisions.
Multiplex assay panels for outpatient respiratory infections and sexually transmitted infections to inform diagnosis and treatment.
Regional and national respiratory trend reports and interactive dashboards to inform clinical and public health awareness.
Recorded webinars, whitepapers and articles explaining diagnostic methods, interpretation and antimicrobial stewardship implications.
Central laboratory service that delivers next-day PCR results across a broad menu of infectious pathogens to support clinical treatment decisions.
Multiplex assay panels for outpatient respiratory infections and sexually transmitted infections to inform diagnosis and treatment.
Regional and national respiratory trend reports and interactive dashboards to inform clinical and public health awareness.
Recorded webinars, whitepapers and articles explaining diagnostic methods, interpretation and antimicrobial stewardship implications.
Expertise Areas
- Infectious disease molecular diagnostics
- High-throughput laboratory operations
- Antimicrobial resistance detection and reporting
- Pathogen surveillance and epidemiologic trend reporting
Key Technologies
- Polymerase chain reaction (PCR)
- Multiplex PCR assays
- Molecular assays for resistance gene detection
- High-throughput laboratory automation
News & Updates
Webinar discussing the clinical value of next-morning PCR diagnostics and policy considerations.
Announced ribbon-cutting of a new campus at UPS Healthcare Labport with a $45.5M investment, doubling testing capacity to five million patient samples annually and expanding nationwide next-morning infectious disease testing access.
Webinar discussing the clinical value of next-morning PCR diagnostics and policy considerations.
Announced ribbon-cutting of a new campus at UPS Healthcare Labport with a $45.5M investment, doubling testing capacity to five million patient samples annually and expanding nationwide next-morning infectious disease testing access.